Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Taysha Gene Therapies Inc (NASDAQ: TSHA) closed at $2.93 in the last session, up 5.02% from day before closing price of $2.79. In other words, the price has increased by $5.02 from its previous closing price. On the day, 5.77 million shares were traded. TSHA stock price reached its highest trading level at $3.0 during the session, while it also had its lowest trading level at $2.75.
Ratios:
We take a closer look at TSHA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 628959680 and an Enterprise Value of 573994816. For the stock, the TTM Price-to-Sale (P/S) ratio is 87.11 while its Price-to-Book (P/B) ratio in mrq is 10.91. Its current Enterprise Value per Revenue stands at 79.457 whereas that against EBITDA is -6.957.
Stock Price History:
The Beta on a monthly basis for TSHA is 1.06, which has changed by -0.013468027 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is 63.07%, while the 200-Day Moving Average is calculated to be 52.06%.
Shares Statistics:
According to the various share statistics, TSHA traded on average about 2.61M shares per day over the past 3-months and 4127650 shares per day over the past 10 days. A total of 205.05M shares are outstanding, with a floating share count of 176.26M. Insiders hold about 17.89% of the company’s shares, while institutions hold 75.83% stake in the company. Shares short for TSHA as of 1745971200 were 26060148 with a Short Ratio of 9.98, compared to 1743379200 on 21631407. Therefore, it implies a Short% of Shares Outstanding of 26060148 and a Short% of Float of 14.78.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
